Placebo-rituximab

DRUG2 trials

Sponsors

Assistance Publique - Hôpitaux de Paris

Conditions

Eosinophilic Granulomatosis With PolyangiitisEosinophilic Granulomatosis With Polyangiitis (EGPA)

Phase 3

Rituximab in Eosinophilic Granulomatosis With Polyangiitis

CompletedNCT02807103

Assistance Publique - Hôpitaux de ParisEosinophilic Granulomatosis With Polyangiitis (EGPA)

Start: 2016-12-05End: 2020-10-21Updated: 2026-01-15

Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.

CompletedNCT03164473

Assistance Publique - Hôpitaux de ParisEosinophilic Granulomatosis With Polyangiitis

Start: 2018-03-07End: 2024-09-23Updated: 2025-11-20

Related Papers

EPGA-Therapie: Die Rolle von Rituximab – Paradigmenwechsel oder Status quo?

Kompass Autoimmun2026-02-26

Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial.

2025-07-292 citations